116 related articles for article (PubMed ID: 9103520)
21. Selective block of N-methyl-D-aspartic acid (NMDA)-evoked whole-cell currents in mouse cultured spinal neurones by CGP 40116.
D'Hooge R; Raes A; Van Bogaert PP; Geelhand M; De Deyn PP
Br J Pharmacol; 1997 Jan; 120(2):211-4. PubMed ID: 9117111
[TBL] [Abstract][Full Text] [Related]
22. Glycine and calcium-dependent effects of lead on N-methyl-D-aspartate receptor function in rat hippocampal neurons.
Marchioro M; Swanson KL; Aracava Y; Albuquerque EX
J Pharmacol Exp Ther; 1996 Oct; 279(1):143-53. PubMed ID: 8858987
[TBL] [Abstract][Full Text] [Related]
23. State-dependent NMDA receptor antagonism by Ro 8-4304, a novel NR2B selective, non-competitive, voltage-independent antagonist.
Kew JN; Trube G; Kemp JA
Br J Pharmacol; 1998 Feb; 123(3):463-72. PubMed ID: 9504387
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of action of galantamine on N-methyl-D-aspartate receptors in rat cortical neurons.
Moriguchi S; Marszalec W; Zhao X; Yeh JZ; Narahashi T
J Pharmacol Exp Ther; 2004 Sep; 310(3):933-42. PubMed ID: 15121761
[TBL] [Abstract][Full Text] [Related]
25. N-methyl-D-aspartate- or glutamate-mediated toxicity in cultured rat cortical neurons is antagonized by FPL 15896AR.
Black MA; Tremblay R; Mealing G; Ray R; Durkin JP; Whitfield JF; Blosser J; Morley P
J Neurochem; 1995 Nov; 65(5):2170-7. PubMed ID: 7595504
[TBL] [Abstract][Full Text] [Related]
26. Potency, voltage-dependency, agonist concentration-dependency, blocking kinetics and partial untrapping of the uncompetitive N-methyl-D-aspartate (NMDA) channel blocker memantine at human NMDA (GluN1/GluN2A) receptors.
Gilling KE; Jatzke C; Hechenberger M; Parsons CG
Neuropharmacology; 2009 Apr; 56(5):866-75. PubMed ID: 19371579
[TBL] [Abstract][Full Text] [Related]
27. Selective antagonism of native and cloned kainate and NMDA receptors by polyamine-containing toxins.
Brackley PT; Bell DR; Choi SK; Nakanishi K; Usherwood PN
J Pharmacol Exp Ther; 1993 Sep; 266(3):1573-80. PubMed ID: 7690404
[TBL] [Abstract][Full Text] [Related]
28. Remacemide hydrochloride and ARL 15896AR lack abuse potential: additional differences from other uncompetitive NMDA antagonists.
Hudzik TJ; Freedman L; Palmer GC
Epilepsia; 1996 Jun; 37(6):544-50. PubMed ID: 8641231
[TBL] [Abstract][Full Text] [Related]
29. Modulation of N-methyl-D-aspartate receptors by donepezil in rat cortical neurons.
Moriguchi S; Zhao X; Marszalec W; Yeh JZ; Narahashi T
J Pharmacol Exp Ther; 2005 Oct; 315(1):125-35. PubMed ID: 15951396
[TBL] [Abstract][Full Text] [Related]
30. Potent antihyperalgesic activity without tolerance produced by glycine site antagonist of N-methyl-D-aspartate receptor GV196771A.
Quartaroli M; Carignani C; Dal Forno G; Mugnaini M; Ugolini A; Arban R; Bettelini L; Maraia G; Belardetti F; Reggiani A; Trist DG; Ratti E; Di Fabio R; Corsi M
J Pharmacol Exp Ther; 1999 Jul; 290(1):158-69. PubMed ID: 10381772
[TBL] [Abstract][Full Text] [Related]
31. Agonist response kinetics of N-methyl-D-aspartate receptors in neurons cultured from rat cerebral cortex and cerebellum: evidence for receptor heterogeneity.
Priestley T; Kemp JA
Mol Pharmacol; 1993 Dec; 44(6):1252-7. PubMed ID: 7903418
[TBL] [Abstract][Full Text] [Related]
32. Neuroprotection by tosyl-polyamine derivatives through the inhibition of ionotropic glutamate receptors.
Masuko T; Namiki R; Nemoto Y; Miyake M; Kizawa Y; Suzuki T; Kashiwagi K; Igarashi K; Kusama T
J Pharmacol Exp Ther; 2009 Nov; 331(2):522-30. PubMed ID: 19644042
[TBL] [Abstract][Full Text] [Related]
33. Direct inhibitory effect of fluoxetine on N-methyl-D-aspartate receptors in the central nervous system.
Szasz BK; Mike A; Karoly R; Gerevich Z; Illes P; Vizi ES; Kiss JP
Biol Psychiatry; 2007 Dec; 62(11):1303-9. PubMed ID: 17659262
[TBL] [Abstract][Full Text] [Related]
34. Rotenone reduces Mg2+-dependent block of NMDA currents in substantia nigra dopamine neurons.
Wu YN; Johnson SW
Neurotoxicology; 2009 Mar; 30(2):320-5. PubMed ID: 19428506
[TBL] [Abstract][Full Text] [Related]
35. Enhancement of NMDA-induced current by the putative NR2B selective antagonist ifenprodil.
Zhang XX; Bunney BS; Shi WX
Synapse; 2000 Jul; 37(1):56-63. PubMed ID: 10842351
[TBL] [Abstract][Full Text] [Related]
36. Novel adamantane derivatives act as blockers of open ligand-gated channels and as anticonvulsants.
Antonov SM; Johnson JW; Lukomskaya NY; Potapyeva NN; Gmiro VE; Magazanik LG
Mol Pharmacol; 1995 Mar; 47(3):558-67. PubMed ID: 7535380
[TBL] [Abstract][Full Text] [Related]
37. Effect of Conantokin G on NMDA receptor-mediated spontaneous EPSCs in cultured cortical neurons.
Alex AB; Baucum AJ; Wilcox KS
J Neurophysiol; 2006 Sep; 96(3):1084-92. PubMed ID: 16760339
[TBL] [Abstract][Full Text] [Related]
38. An allosteric interaction between the NMDA receptor polyamine and ifenprodil sites in rat cultured cortical neurones.
Kew JN; Kemp JA
J Physiol; 1998 Oct; 512 ( Pt 1)(Pt 1):17-28. PubMed ID: 9729614
[TBL] [Abstract][Full Text] [Related]
39. In vitro and in vivo characterization of conantokin-R, a selective NMDA receptor antagonist isolated from the venom of the fish-hunting snail Conus radiatus.
White HS; McCabe RT; Armstrong H; Donevan SD; Cruz LJ; Abogadie FC; Torres J; Rivier JE; Paarmann I; Hollmann M; Olivera BM
J Pharmacol Exp Ther; 2000 Jan; 292(1):425-32. PubMed ID: 10604979
[TBL] [Abstract][Full Text] [Related]
40. A rapid inhibition of NMDA receptor current by corticosterone in cultured hippocampal neurons.
Liu L; Wang C; Ni X; Sun J
Neurosci Lett; 2007 Jun; 420(3):245-50. PubMed ID: 17540506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
